BTIG Remains Positive on Shire's (SHPG) Orphan Disease Treatment Pipeline; Baxalta Deal Still in Motion
BTIG offers commentary on Shire plc (Nasdaq: SHPG) with respect to preliminary pro forma analysis with Baxalta (NYSE: BXLT) and ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)